{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:14:19Z","timestamp":1778260459111,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["295334"],"award-info":[{"award-number":["295334"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["307232"],"award-info":[{"award-number":["307232"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012224","name":"Stanley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jamda.2019.07.009","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T08:02:14Z","timestamp":1566806534000},"page":"1488-1494.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Marjaana","family":"Koponen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piia","family":"Lavikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.07.009_bib1","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.4088\/JCP.15m10458","article-title":"Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer's disease","volume":"78","author":"Koponen","year":"2017","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.009_bib2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-016-3881-3","article-title":"Use of antipsychotics increases the risk of fracture: A systematic review and meta-analysis","volume":"28","author":"Lee","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jamda.2019.07.009_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review","volume":"33","author":"Sacchetti","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.jamda.2019.07.009_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1533317510390351","article-title":"Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: A literature review of evidence","volume":"26","author":"Mittal","year":"2011","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jamda.2019.07.009_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bcp.12985","article-title":"Use of antipsychotics and risk of myocardial infarction: A systematic review and meta-analysis","volume":"82","author":"Yu","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2019.07.009_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pds.3804","article-title":"Antipsychotic drug exposure and risk of pneumonia: A systematic review and meta-analysis of observational studies","volume":"24","author":"Nos\u00e8","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2019.07.009_bib7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.chest.2016.06.004","article-title":"Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and those without Alzheimer disease","volume":"150","author":"Tolppanen","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2019.07.009_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.009_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JAD-160671","article-title":"Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with Alzheimer's disease","volume":"56","author":"Koponen","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.07.009_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4483","article-title":"Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults","volume":"32","author":"Johnell","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.009_bib11","doi-asserted-by":"crossref","first-page":"41035","DOI":"10.1038\/srep41035","article-title":"Potentially high-risk medication categories and unplanned hospitalizations: A case-time-control study","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jamda.2019.07.009_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1176\/appi.ps.201300093","article-title":"Risk of hospitalization and use of first- versus second-generation antipsychotics among nursing home residents","volume":"65","author":"Aparasu","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jamda.2019.07.009_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","article-title":"Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer\u2019s disease","volume":"28","author":"Orsel","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2019.07.009_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.07.009_bib15","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","year":"1994"},{"key":"10.1016\/j.jamda.2019.07.009_bib16","doi-asserted-by":"crossref","first-page":"e012100","DOI":"10.1136\/bmjopen-2016-012100","article-title":"Cohort profile: The Finnish medication and Alzheimer's disease (MEDALZ) study","volume":"6","author":"Tolppanen","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2019.07.009_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods - a second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jamda.2019.07.009_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CLEP.S116160","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jamda.2019.07.009_bib20","doi-asserted-by":"crossref","first-page":"e0184070","DOI":"10.1371\/journal.pone.0184070","article-title":"Drug exposure in register-based research-an expert-opinion based evaluation of methods","volume":"12","author":"Tanskanen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2019.07.009_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eurpsy.2017.02.486","article-title":"Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study","volume":"43","author":"Tapiainen","year":"2017","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.009_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: A population-based cohort study","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2019.07.009_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40263-017-0421-4","article-title":"A\u00a0retrospective cohort study of acute kidney injury risk associated with antipsychotics","volume":"31","author":"Jiang","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2019.07.009_bib25","first-page":"CD003476","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2019.07.009_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.07.009_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00406-016-0723-4","article-title":"Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials","volume":"267","author":"Wolf","year":"2017","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jamda.2019.07.009_bib28","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jamda.2019.07.009_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: A state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jamda.2019.07.009_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2019.07.009_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","article-title":"Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system","volume":"135","author":"Leung","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jamda.2019.07.009_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bone.2005.07.005","article-title":"Risk of hip\/femur fractures in patients using antipsychotics","volume":"37","author":"Hugenholtz","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jamda.2019.07.009_bib33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00198-008-0826-5","article-title":"Antipsychotic use and the risk of hip\/femur fracture: A population-based case-control study","volume":"20","author":"Pouwels","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jamda.2019.07.009_bib34","doi-asserted-by":"crossref","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-risk-increasing drugs: A systematic review and meta-analysis: II. Psychotropics","volume":"19","author":"Seppala","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.07.009_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1532-5415.2011.03853.x","article-title":"Comparative safety of antipsychotic medications in nursing home residents","volume":"60","author":"Huybrechts","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.07.009_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish hospital discharge register: A systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019305614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019305614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:19:18Z","timestamp":1761506358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861019305614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1525861019305614"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.07.009","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}